Torthaí cuardaigh - Nachbur, Ueli
- 1 - 14 toradh as 14 á dtaispeáint
-
1
NOD Signaling and Cell Death de réir Heim, Valentin J., Stafford, Che A., Nachbur, Ueli
Foilsithe / Cruthaithe 2019Téacs -
2
XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures de réir Ellwanger, Kornelia, Briese, Selina, Arnold, Christine, Kienes, Ioannis, Heim, Valentin, Nachbur, Ueli, Kufer, Thomas A
Foilsithe / Cruthaithe 2019Téacs -
3
-
4
A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity de réir Heim, Valentin J, Dagley, Laura F, Stafford, Che A, Hansen, Fynn M, Clayer, Elise, Bankovacki, Aleksandra, Webb, Andrew I, Lucet, Isabelle S, Silke, John, Nachbur, Ueli
Foilsithe / Cruthaithe 2020Téacs -
5
XIAP acts as a switch between type I and type II FAS-induced apoptosis signalling de réir Jost, Philipp J., Grabow, Stephanie, Gray, Daniel, McKenzie, Mark D., Nachbur, Ueli, Huang, David C.S., Bouillet, Philippe, Thomas, Helen E., Borner, Christoph, Silke, John, Strasser, Andreas, Kaufmann, Thomas
Foilsithe / Cruthaithe 2009Téacs -
6
Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis de réir Ebert, Gregor, Allison, Cody, Preston, Simon, Cooney, James, Toe, Jesse G., Stutz, Michael D., Ojaimi, Samar, Baschuk, Nikola, Nachbur, Ueli, Torresi, Joseph, Silke, John, Begley, C. Glenn, Pellegrini, Marc
Foilsithe / Cruthaithe 2015Téacs -
7
Oligomerization‐driven MLKL ubiquitylation antagonizes necroptosis de réir Liu, Zikou, Dagley, Laura F, Shield‐Artin, Kristy, Young, Samuel N, Bankovacki, Aleksandra, Wang, Xiangyi, Tang, Michelle, Howitt, Jason, Stafford, Che A, Nachbur, Ueli, Fitzgibbon, Cheree, Garnish, Sarah E, Webb, Andrew I, Komander, David, Murphy, James M, Hildebrand, Joanne M, Silke, John
Foilsithe / Cruthaithe 2021Téacs -
8
Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus de réir Ebert, Gregor, Preston, Simon, Allison, Cody, Cooney, James, Toe, Jesse G., Stutz, Michael D., Ojaimi, Samar, Scott, Hamish W., Baschuk, Nikola, Nachbur, Ueli, Torresi, Joseph, Chin, Ruth, Colledge, Danielle, Li, Xin, Warner, Nadia, Revill, Peter, Bowden, Scott, Silke, John, Begley, C. Glenn, Pellegrini, Marc
Foilsithe / Cruthaithe 2015Téacs -
9
TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1 de réir Etemadi, Nima, Chopin, Michael, Anderton, Holly, Tanzer, Maria C, Rickard, James A, Abeysekera, Waruni, Hall, Cathrine, Spall, Sukhdeep K, Wang, Bing, Xiong, Yuquan, Hla, Timothy, Pitson, Stuart M, Bonder, Claudine S, Wong, Wendy Wei-Lynn, Ernst, Matthias, Smyth, Gordon K, Vaux, David L, Nutt, Stephen L, Nachbur, Ueli, Silke, John
Foilsithe / Cruthaithe 2015Téacs -
10
Correction: TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1 de réir Etemadi, Nima, Chopin, Michael, Anderton, Holly, Tanzer, Maria C, Rickard, James A, Abeysekera, Waruni, Hall, Cathrine, Spall, Sukhdeep K, Wang, Bing, Xiong, Yuquan, Hla, Timothy, Pitson, Stuart M, Bonder, Claudine S, Wong, Wendy Wei-Lynn, Ernst, Matthias, Smyth, Gordon K, Vaux, David L, Nutt, Stephen L, Nachbur, Ueli, Silke, John
Foilsithe / Cruthaithe 2017Téacs -
11
TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice de réir Rickard, James A, Anderton, Holly, Etemadi, Nima, Nachbur, Ueli, Darding, Maurice, Peltzer, Nieves, Lalaoui, Najoua, Lawlor, Kate E, Vanyai, Hannah, Hall, Cathrine, Bankovacki, Aleks, Gangoda, Lahiru, Wong, Wendy Wei-Lynn, Corbin, Jason, Huang, Chunzi, Mocarski, Edward S, Murphy, James M, Alexander, Warren S, Voss, Anne K, Vaux, David L, Kaiser, William J, Walczak, Henning, Silke, John
Foilsithe / Cruthaithe 2014Téacs -
12
A type III effector antagonises death receptor signalling during bacterial gut infection de réir Pearson, Jaclyn S, Giogha, Cristina, Ong, Sze Ying, Kennedy, Catherine L, Kelly, Michelle, Robinson, Keith S, Wong, Tania, Mansell, Ashley, Riedmaier, Patrice, Oates, Clare VL, Zaid, Ali, Mühlen, Sabrina, Crepin, Valerie F, Marches, Olivier, Ang, Ching-Seng, Williamson, Nicholas A, O’Reilly, Lorraine A, Bankovacki, Aleksandra, Nachbur, Ueli, Infusini, Giuseppe, Webb, Andrew I, Silke, John, Strasser, Andreas, Frankel, Gad, Hartland, Elizabeth L
Foilsithe / Cruthaithe 2013Téacs -
13
EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation de réir Pearson, Jaclyn S., Giogha, Cristina, Mühlen, Sabrina, Nachbur, Ueli, Pham, Chi L. L., Zhang, Ying, Hildebrand, Joanne M., Oates, Clare V., Lung, Tania Wong Fok, Ingle, Danielle, Dagley, Laura F., Bankovacki, Aleksandra, Petrie, Emma J., Schroeder, Gunnar N., Crepin, Valerie F., Frankel, Gad, Masters, Seth L., Vince, James, Murphy, James M., Sunde, Margaret, Webb, Andrew I., Silke, John, Hartland, Elizabeth L.
Foilsithe / Cruthaithe 2017Téacs -
14
Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors de réir Calleja, Dale J., Kuchel, Nathan, Lu, Bernadine G. C., Birkinshaw, Richard W., Klemm, Theresa, Doerflinger, Marcel, Cooney, James P., Mackiewicz, Liana, Au, Amanda E., Yap, Yu Q., Blackmore, Timothy R, Katneni, Kasiram, Crighton, Elly, Newman, Janet, Jarman, Kate E., Call, Melissa J., Lechtenberg, Bernhard C., Czabotar, Peter E., Pellegrini, Marc, Charman, Susan A., Lowes, Kym N., Mitchell, Jeffrey P., Nachbur, Ueli, Lessene, Guillaume, Komander, David
Foilsithe / Cruthaithe 2022Téacs